Reducing Exercise Sensitivity with Exposure Training for Acute Coronary Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Acute Coronary Syndrome+4 More
Reducing Exercise Sensitivity with Exposure Training - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a home-based exposure therapy intervention to help people with a history of ACS be less afraid of exercise sensations and improve participation in cardiac rehabilitation and physical activity.

Eligible Conditions
  • Acute Coronary Syndrome
  • Anxiety
  • Physical Inactivity

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

6 Primary · 2 Secondary · Reporting Duration: baseline and after pilot study completion (4 weeks)

Week 4
Proportion of participants that are adherent to the intervention (Intervention Adherence)
Week 4
Proportion of participants who complete the outcome assessments upon program completion
Proportion of participants who report adequate acceptability of the intervention
Proportion of participants who report adequate appropriateness of the intervention
Interventional procedure
Week 4
Cephalopelvic Proportion
Week 4
Change in Exercise Sensitivity Questionnaire Score
Change in self-reported physical activity and sitting

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Reducing Exercise Sensitivity with Exposure Training
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Reducing Exercise Sensitivity with Exposure Training · No Placebo Group · N/A

Reducing Exercise Sensitivity with Exposure Training
Behavioral
Experimental Group · 1 Intervention: Reducing Exercise Sensitivity with Exposure Training · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and after pilot study completion (4 weeks)

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,380 Previous Clinical Trials
3,446,726 Total Patients Enrolled
2 Trials studying Acute Coronary Syndrome
550 Patients Enrolled for Acute Coronary Syndrome
Columbia UniversityLead Sponsor
1,282 Previous Clinical Trials
1,613,052 Total Patients Enrolled
9 Trials studying Acute Coronary Syndrome
3,748 Patients Enrolled for Acute Coronary Syndrome
Ian Kronish, MDStudy DirectorFlorence Irving Associate Professor of Medicine
2 Previous Clinical Trials
2,010 Total Patients Enrolled
1 Trials studying Acute Coronary Syndrome
10 Patients Enrolled for Acute Coronary Syndrome
Andrea T Duran, PhDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Acute Coronary Syndrome
40 Patients Enrolled for Acute Coronary Syndrome

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have been diagnosed with ACS within the past 12 months.
You have a tablet or smartphone to conduct Zoom video visits.
You must be between the ages of 18 and 65 years.
You have a strong interest in participating in the study.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 29th, 2021

Last Reviewed: October 15th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References